![](/img/cover-not-exists.png)
Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: Results from a 10-week, double-blind, placebo-controlled, dose-titration study
Joel M. Neutel, Vardaman Buckalew, Steven G. Chrysant, William J. Mroczek, Dennis A. Ruff, Michael WeberVolume:
137
Year:
1999
Language:
english
DOI:
10.1016/s0002-8703(99)70467-9
File:
PDF, 155 KB
english, 1999